The global VCF market was valued at over $1.1 billion in 2024.
It is projected to grow at a CAGR of 5.2%, reaching over $1.6 billion by 2031.
The report covers two primary segments:
Percutaneous Vertebral Augmentation (PVA)
Vertebroplasty
Market Data Included
Unit Sales
Average Selling Prices (ASPs)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts to 2031
Historical Data to 2024
Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitor Analysis
Global VCF Market Trends
All regions are projected to experience market growth, though the rate of growth varies significantly:
Middle East is expected to lead in growth rate.
Followed by Africa and Asia-Pacific.
North America has the lowest growth forecast, reflecting market maturity.
Western Europe is similarly mature but ranks third globally due to its strong infrastructure.
Market growth in less mature regions is driven by increased diagnosis, rising elderly populations, and better access to surgical solutions.
Global VCF Market Share Insights
1 Medtronic
Global market leader in 2024, holding close to 50% of the total market value.
Strong dominance in North America and Western Europe.
Offers the KyphX® system and leads the PVA segment in multiple countries.
2 Stryker
Ranked second globally in the VCF market.
Products include:
AutoPlex™ cement mixer and delivery system
VertaPlex™, VertaPlex HV™, and SpinePlex® bone cements
iVAS™ PVA system
AVAflex Balloon System and AVAmax®
Known for cost-effective alternatives and ease of use compared to competitors.
3 DePuy Synthes
Third-largest competitor globally in 2024.
Product portfolio includes:
CONFIDENCE™ Spinal Cement System
VERTECEM™ V+ bone cement
Strong presence in North America and Western Europe.
Focused on controlled delivery and stability in vertebral augmentation procedures.
Market Segmentation Summary
Vertebroplasty
Percutaneous Vertebral Augmentation (PVA)
Research Scope Summary
Regions Covered
North America: Canada, United States
Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
Base Year: 2024
Forecast Period: 2025–2031
Historical Data: 2021–2023
Quantitative Data
Procedure Numbers
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices
Qualitative Data
Market Growth Trends
Market Limiters
Competitive Analysis
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook